Current guidelines from the U.S. Preventive Services Task Force recommend a one-time abdominal ultrasound for men aged 65 to 75 who have ever smoked, the group at highest risk of developing an abdominal aortic aneurysm (AAA). For men in the same age range who have never smoked, the recommendation shifts to selective screening based on individual risk factors rather than routine screening for everyone. Women and younger adults are not included in the standard recommendation, a gap that has generated ongoing debate as newer evidence accumulates. The guidelines sound straightforward, but the reasoning behind who gets screened, how often follow-up happens, and what triggers treatment is layered with clinical nuance worth understanding.
What the USPSTF Actually Recommends
The USPSTF issued its most recent recommendation statement on AAA screening in 2019. It assigns a “B” grade to one-time screening with ultrasound in men aged 65 to 75 who have ever smoked, meaning there is high certainty of at least moderate net benefit. For men in that same age window who have never smoked, it assigns a “C” grade, which means clinicians should selectively offer screening based on individual circumstances rather than blanket testing. For women who have never smoked and have no family history of AAA, the task force recommends against screening entirely, finding that the potential harms outweigh the benefits in that group. For women who have smoked or have a family history, the evidence was judged insufficient to make a firm recommendation either way.
1PubMed. Screening for Abdominal Aortic Aneurysm: US Preventive Services Task Force Recommendation StatementThese categories matter because AAA is a condition where the stakes are dramatically different depending on whether it is caught early or found only after rupture. An aortic aneurysm is a ballooning of the body’s largest artery, and when it ruptures, mortality is devastating. A study modeling risk factors for ruptured AAA found that the accumulation of just a few risk factors pushed in-hospital mortality from roughly 11% up to 89%.
2PubMed Central. Prediction of in-hospital mortality after ruptured abdominal aortic aneurysm repair using an artificial neural networkWhy Smoking Dominates the Screening Criteria
Smoking is not just one risk factor among many for AAA. It eclipses everything else. In a large screening study of over 114,000 veterans, a history of ever smoking carried an odds ratio near 3 for aneurysms in the 3 to 4 cm range, and above 5 for aneurysms 4 cm and larger. Researchers estimated that smoking was responsible for three-quarters of the excess prevalence of larger aneurysms. The dose-response relationship is linear: the longer and more heavily a person smoked, the greater the risk, with duration of smoking appearing more important than daily cigarette count, especially in former smokers.
3PubMed Central. Understanding the effects of tobacco smoke on the pathogenesis of aortic aneurysmWhat makes smoking’s role in AAA unusual is its outsized strength compared with other vascular diseases. A systematic review found that the association between smoking and AAA was roughly two and a half times greater than the association between smoking and coronary heart disease. That disproportionate risk is part of what convinced the USPSTF to use smoking history as the primary filter for who should be screened, rather than recommending screening for all older men.
4PubMed Central. Understanding the effects of tobacco smoke on the pathogenesis of aortic aneurysmQuitting does help, but the risk does not vanish. Data from the ARIC study, which followed participants for 24 years, found that smokers who quit between study visits had about a 29% lower lifetime risk of AAA compared with those who kept smoking. Still, their risk remained higher than people who had quit before the study began. At age 45, the overall lifetime risk of AAA was about 5.6%, but that figure rose to 8.2% for men and 10.5% for current smokers.
5PubMed Central. Lifetime Risk and Risk Factors for Abdominal Aortic Aneurysm in a 24-Year Prospective Study: The ARIC StudyThe Evidence That Screening Saves Lives
The strongest evidence for AAA screening comes from four large randomized trials conducted in the UK, Denmark, Western Australia, and Italy, with the UK’s Multicentre Aneurysm Screening Study (MASS) providing the longest follow-up. In its final analysis, the group of men invited to screening had a 42% reduction in AAA-related death compared with the uninvited group. There was also a small but statistically significant 3% reduction in overall mortality.
6PubMed Central. Final follow-up of the Multicentre Aneurysm Screening Study (MASS) randomized trial of abdominal aortic aneurysm screeningA meta-analysis pooling these trials confirmed the picture. Screening cut AAA-related mortality roughly in half, led to about three times as many planned (elective) operations, and cut emergency operations by nearly half. The long-term pooled data showed a significant reduction in overall mortality as well, though the effect was modest since AAA accounts for a small fraction of total deaths in older men.
7European Journal of Vascular and Endovascular Surgery. Screening for Abdominal Aortic Aneurysm: Single Centre Randomised Controlled TrialThe key mechanism is simple: screening catches aneurysms while they are small enough to monitor and, when they grow large enough, repair under controlled conditions. Elective surgery carries far lower risk than emergency repair after a rupture. Pooled 30-day mortality after elective endovascular repair is about 1.2%, and about 3.3% after open repair.
8PubMed Central. Endovascular and Open Repair of Abdominal Aortic AneurysmHow the Screening Works
AAA screening is an abdominal ultrasound, a painless test that typically takes under 10 minutes. It does not require any preparation from the patient beyond a loose-fitting shirt. The test measures the diameter of the abdominal aorta and flags anything at or above 3 cm as an aneurysm.
Ultrasound is well suited to this job. A meta-analysis of non-radiologist-performed ultrasound for AAA detection found pooled sensitivity above 97% and specificity above 98%, meaning both false negatives and false positives are rare.
9PubMed. Diagnostic accuracy of non-radiologist performed ultrasound for abdominal aortic aneurysm: systematic review and meta-analysisOne quirk worth knowing: ultrasound consistently measures aortic diameter slightly smaller than CT does, with the difference averaging a few millimeters. This matters because surveillance thresholds and repair decisions are based on specific size cutoffs. The direction of the bias is at least consistent, so it does not usually cause confusion as long as the same imaging method is used throughout a patient’s follow-up.
10PubMed. Accuracy of ultrasound in a screening programme for abdominal aortic aneurysmsWhat Happens After a Small Aneurysm Is Found
Most aneurysms detected by screening are small, well below the threshold for surgery. These get monitored with periodic ultrasound. How often you go back for scans depends on the size of the aneurysm.
The Society for Vascular Surgery recommends surveillance every three years for aneurysms measuring 3.0 to 3.9 cm and yearly for those 4.0 to 4.9 cm in men. Research supports this general framework. A meta-analysis found that surveillance intervals could safely be extended to three years for aneurysms in the 3.0 to 3.9 cm range while keeping the annual rupture risk below 1%.
11JAMA. Surveillance Intervals for Small Abdominal Aortic Aneurysms: A Meta-analysisGrowth rates for small aneurysms average about 2 mm per year, but that number hides a lot of variation. A study tracking individual growth patterns found that roughly 10% of aneurysms barely grew at all, while 28% grew faster than 2.5 mm per year. Most displayed steady, linear growth, but a small fraction showed sudden acceleration. Encouragingly, no patient with an aneurysm under 4.25 cm exceeded repair thresholds within two years of measurement.
12JAMA Surgery. Evaluating Growth Patterns of Abdominal Aortic Aneurysm Diameter With Serial Computed Tomography SurveillanceBoth growth rate and rupture risk increase with aneurysm size. For every 0.5 cm increase in diameter, growth speeds up by about 0.5 mm per year and rupture risk roughly doubles.
13PubMed Central. Systematic review and meta-analysis of the growth and rupture rates of small abdominal aortic aneurysms: implications for surveillance intervals and their cost-effectivenessWhen Repair Becomes Necessary
The traditional repair thresholds are 5.5 cm for men and 5.0 cm for women. Surgery is also indicated if the aneurysm is growing rapidly (generally more than 1 cm per year) or causing symptoms, regardless of size.
14PubMed Central. Endovascular and Open Repair of Abdominal Aortic AneurysmThese thresholds have been in place for years, but recent modeling work suggests they may be more conservative than necessary, at least for patients in good overall health. A simulation study found that for a 60-year-old woman in average health, the optimal repair size to minimize AAA-related mortality was about 6.1 cm, and for a 60-year-old man it was 6.9 cm. Life expectancy changed by less than two months across a wide range of repair sizes around those optima, which suggests the exact cutoff matters less than having a reasonable one.
15PubMed Central. Size thresholds for repair of abdominal aortic aneurysms warrant reconsiderationThat said, these models assume average health. For someone with significant heart disease or lung disease, the risk of the surgery itself may outweigh the risk of the aneurysm, shifting the calculus in favor of continued surveillance. And for women, the lower threshold exists because their aneurysms tend to rupture at smaller diameters.
The Gap in Guidelines for Women
AAA is far less common in women than in men, which is the main reason screening guidelines have historically focused on men. But when women do develop an aneurysm, their outcomes tend to be worse. The natural history of AAA in women appears to be more aggressive, with faster expansion, a higher tendency to rupture at smaller diameters, and higher mortality after rupture. The protective role of estrogen likely explains the lower initial incidence, but that protection fades after menopause.
16PubMed Central. Abdominal aortic aneurysms in womenA study of targeted screening in women with a smoking history found an AAA prevalence of 0.8% in a selectively screened group compared with 0.4% in a general screening group, with 71% of the selective group reporting smoking history.
17PubMed. Targeted screening for abdominal aortic aneurysm in high-risk women with a smoking historyThose numbers are lower than what you see in men, but they are not trivial, and they climb when you layer on additional risk factors. The USPSTF currently labels the evidence for screening women who smoke as “insufficient,” which does not mean screening is unhelpful in this group. It means the data are too thin to make a confident population-level recommendation. Several vascular surgery societies have pushed for broader screening criteria that include high-risk women, and the debate is far from settled.
Family History as an Independent Risk Factor
Having a first-degree relative with AAA substantially raises your risk, independent of smoking. A systematic review and meta-analysis of family screening studies found that roughly one in five male relatives and one in sixteen female relatives of AAA patients had an aneurysm themselves. About one in six patients with a known AAA had at least one affected relative. The authors concluded that screening strategies should encompass all first-degree relatives, both male and female, regardless of whether the index patient reports a family history.
18The Lancet. Family screening for abdominal aortic aneurysm: a systematic review and meta-analysisMany guidelines already recognize family history as a reason to consider screening outside the standard age and sex criteria, but the USPSTF has not formally carved out a separate recommendation for it. If you have a parent or sibling who had an AAA, bringing it up with your doctor is worth doing even if you do not otherwise meet the screening criteria.
Medications That May Slow Aneurysm Growth
Once an aneurysm is found, there is no approved drug to shrink it. But several medications already prescribed for other conditions show signs of slowing growth. The most intriguing data involve metformin, a common diabetes drug. In the UK Aneurysm Growth Study, metformin was associated with slower aneurysm growth by roughly 0.38 mm per year, and ACE inhibitors showed a similar effect.
19PubMed Central. Influence of cardiometabolic medications on abdominal aortic aneurysm growth in the UK Aneurysm Growth StudyA separate systematic review and meta-analysis found that both metformin and statins were statistically significant in slowing AAA growth, though the quality of evidence was rated very low due to high heterogeneity and risk of bias in the underlying studies.
20European Journal of Vascular and Endovascular Surgery. Systematic Review Exploring Drug Re-Purposing for Treatment of Abdominal Aortic AneurysmsThe same UK study found that continued smoking was associated with faster growth by about 0.3 mm per year. That finding reinforces the importance of quitting even after an aneurysm is already present. None of these medications are formally indicated for AAA management, but if you are already taking metformin or a statin for other reasons, there may be a secondary benefit that your vascular team is aware of.
21PubMed Central. Influence of cardiometabolic medications on abdominal aortic aneurysm growth in the UK Aneurysm Growth StudyIs Screening Cost-Effective
Screening sounds expensive when you imagine millions of ultrasounds, but the economics work out favorably over time. The MASS trial’s 10-year cost-effectiveness analysis found an incremental cost of about £100 per man invited and an incremental cost-effectiveness ratio of roughly £7,600 per life-year gained.
22BMJ. Screening men for abdominal aortic aneurysm: 10 year mortality and cost effectiveness results from the randomised Multicentre Aneurysm Screening StudyAt four years of follow-up, cost-effectiveness was marginal, around £28,400 per life-year gained. But the ratio improved sharply with longer follow-up because the benefits of elective repair over emergency surgery accrue for the rest of a patient’s life.
23PubMed Central. Multicentre aneurysm screening study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results from randomised controlled trialA separate cost-effectiveness analysis using modeling confirmed that ultrasound screening of men beginning at age 65 is both effective and cost-effective in preventing AAA-related death, though the absolute impact at a population level is small because AAA rupture, while deadly, is relatively uncommon.
24PubMed Central. Abdominal aortic aneurysm (AAA): cost-effectiveness of screening, surveillance of intermediate-sized AAA, and management of symptomatic AAABarriers to Getting Screened
Even in countries with organized screening programs, a sizable number of eligible people never show up. Research in the UK found that common reasons included inconvenient clinic times and locations, lack of awareness of what AAA screening involves, and language or literacy barriers. Afro-Caribbean men were disproportionately less likely to attend. When patient-suggested improvements were implemented, uptake rose from about 75% to over 81%.
25PubMed. Improving Abdominal Aortic Aneurysm (AAA) Screening Uptake through Patient EngagementAmong women, the disparities are compounded by the fact that formal screening programs rarely include them. A narrative review found that women in the lowest income brackets were 25 to 45% less likely to receive screening. Uninsured women faced odds ratios of 0.4 to 0.6 compared with insured counterparts, and rural women were 30 to 50% less likely to be screened than urban women. Racial and ethnic disparities were consistently reported as well, with Black, Hispanic, and Native American women less likely to be screened.
26PubMed Central. Socioeconomic Inequities in Abdominal Aortic Aneurysm Screening Uptake Among Women: A Narrative ReviewAI and the Future of Opportunistic Detection
One emerging approach sidesteps the question of who to invite for screening by looking for aneurysms on CT scans patients are already getting for other reasons. Artificial intelligence algorithms trained on abdominal CT images can flag aortic enlargement automatically, catching aneurysms that a radiologist might overlook when reading the scan for an unrelated complaint like kidney stones or abdominal pain. A systematic review of AI tools for opportunistic AAA detection reported mean sensitivity around 95% and specificity near 97%.
27PubMed Central. Diagnostic Accuracy of AI for Opportunistic Screening of Abdominal Aortic Aneurysm in CT: A Systematic Review and Narrative SynthesisThis kind of opportunistic screening could be especially useful for populations that current guidelines miss, such as women with smoking histories or younger patients with strong family histories, who may already be getting CT scans in emergency departments or for other medical workups. The technology is still being validated in real-world settings, but early results suggest it could meaningfully supplement formal screening programs.
28PubMed. Performance assessment of an artificial intelligence algorithm for opportunistic screening of abdominal aortic aneurysmsA separate line of research is working toward blood-based biomarkers that could identify people at elevated risk before imaging. One study identified a two-protein panel (angiopoietin-2 and aggrecan) that, when combined with clinical features, achieved strong predictive performance for adverse aneurysm-related events. The idea of a blood test that tells you whether an ultrasound is worth ordering is still years from clinical use, but the proof of concept is there.
29PubMed. Identification and Evaluation of Blood-Based Biomarkers for Abdominal Aortic Aneurysm